Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer
Document Type
Conference Proceeding
Publication Date
2016
Publication Title
Journal of Clinical Oncology
Additional Publication URL
http://meetinglibrary.asco.org/content/166144-176
Abstract
Published abstract from the 2016 ASCO Annual Meeting.
Rights
Link leads to abstract.
Recommended Citation
Gupta, Niraj K.; Singh, Kirpal; Glass, Timothy; Davis, Chad; Lybik, Mark; Leagre, Christopher; Liebross, Robert H.; Dugan, Thomas; Edwards, Mark; Givens, Stanley; Compton, Julia; Tigges, Thomas; Flanders, Vincent; Mathavan, Vinay; Isch, Andrew; Reeves, David J.; Arevalo, Gabriel; Rowe, Michael; Kaderabek, Douglas; and Arregui, Maurice, "Neoadjuvant gemcitabine and nab-paclitaxel followed by concurrent capecitabine and radiation efficacy in borderline resectable (BR) pancreatic cancer" (2016). Scholarship and Professional Work – COPHS. 202.
https://digitalcommons.butler.edu/cophs_papers/202